Xeris Biopharma Holdings, Inc.: how funds voted at the meeting of 4 Jun 2025
- Ticker
- XERS
- Meeting
- Season
- year to 30 June 2025
- Filers reporting
- 226
- Ballot items
- 3
226 filers on Form N-PX reported votes at the Xeris Biopharma Holdings, Inc. meeting of 4 Jun 2025. The records fall into 3 ballot items. The page lists them in ballot order: items of the company first, then proposals from security holders. Each bar shows how the reporting filers split. It is not the result of the meeting.
This meeting is in the year to 30 June 2025. The latest season on file is the year to 30 June 2026. The page of Xeris Biopharma Holdings, Inc. has the latest meeting.
If the reporting person has not received confirmation of the actual number of votes cast prior to filing a report on Form N-PX, the numbers reported may reflect the number of shares instructed to be cast. A reporting person is not required to amend a previously filed Form N-PX report if the reporting person subsequently receives confirmation of the actual number of votes cast.
The words of the SEC. Source: Form N-PX and its instructions, Special Instructions D.5 and D.8, copied on .
The words of this site: the filer writes each filing. The SEC does not say that it checked the votes. A lender does not vote shares that are on loan. A later filing (Form N-PX/A) can replace an earlier filing, and the site uses the latest.
The figures on this page count the filers that report on Form N-PX and the shares they reported. They do not count all votes cast at the meeting.
The page gives records. It gives no investment advice and no advice on how to vote.
Season on this page: year to 30 June 2025. Filings read through . How the figures are made
The ballot
Item 1: Director elections
3 nominees. 83.3% of the reported votes are for. 39 filers withheld from or voted against at least one nominee.
397 vote records from 77 filers. 3 of the 77 filers that marked the item voted against management.
- Positions of 31 fund families
- For 29
- Abstain or withhold 2
- Against management 2
Item 2: Advisory vote on executive pay (say-on-pay)
305 vote records from 224 filers. 15 of the 218 filers that marked the item voted against management. 6 filers gave no management mark.
- Positions of 38 fund families
- For 35
- Against 3
- Against management 3
Item 3: Audit-related items (auditor ratification)
133 vote records from 77 filers. 1 of the 77 filers that marked the item voted against management.
- Positions of 31 fund families
- For 31
Positions of the fund families
A position is not the vote of each fund. The position of a family is the way most of the shares reported by its filers were voted. Funds of one family can vote in different ways.
KeyForAgainstAbstain or withholdSplit or no voteAgainst management
| Fund family | 2. Say-on-pay | 3. Auditor |
|---|---|---|
| AllianceBernstein | For | No report |
| Allspring | For | No report |
| American Century | Against, against management | For |
| BlackRock and iShares | For | For |
| BNY Mellon | Against, against management | No report |
| Brighthouse Funds | For | For |
| Charles Schwab | For | For |
| Columbia Threadneedle | For | For |
| Dimensional | For | For |
| DWS | For | For |
| Equitable | For | For |
| Federated Hermes | For | For |
| Fidelity | For | For |
| Franklin Templeton | For | No report |
| Global X | For | For |
| Goldman Sachs | For | For |
| Guggenheim and Rydex | For | For |
| Invesco | Against, against management | For |
| J.P. Morgan | For | No report |
| John Hancock and Manulife | For | For |
| Lincoln Financial | For | For |
| MassMutual | For | No report |
| Morgan Stanley, Eaton Vance and Calvert | For | For |
| Nationwide | For | For |
| Neuberger Berman | For | No report |
| Northern Trust and FlexShares | For | For |
| Nuveen and TIAA | For | For |
| Pacific Life funds | For | For |
| PGIM and Prudential | For | For |
| Principal | For | For |
| ProShares and ProFunds | For | For |
| Russell Investments | For | For |
| SEI | For | For |
| State Street and SPDR | For | For |
| T. Rowe Price | For | For |
| Vanguard | For | For |
| Victory Capital | For | For |
| Voya | For | For |
Questions
- How many filers reported votes at the Xeris Biopharma Holdings, Inc. meeting?
- 226 Form N-PX filers reported votes at the meeting of 4 Jun 2025. On say-on-pay, 15 of 218 filers that marked the item voted against management (6.9%).
- Is this the result of the meeting?
- No. The page counts the filers that report on Form N-PX, and the shares they reported. Xeris Biopharma Holdings, Inc. reports the result of a vote on Form 8-K.
- Why does the page show counts only for director elections?
- A director record names the nominee. This site has no page and no row about a person. For director elections it keeps the number of nominees and the split of votes.
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings that list Xeris Biopharma Holdings, Inc. with a meeting date within three days of 4 Jun 2025. A proposal title is the most common wording among filers. Where a wording can name a person, the SEC category is shown. The filers wrote the filings. Filings read through .